GHRC Symposium | How is Real World Evidence Driving Impact in The Drug Life Cycle? | Duke Kunshan University
GHRC Symposium | How is Real World Evidence Driving Impact in The Drug Life Cycle?
Speaker: 
Dr. Jiachen Zhou

RWE Lead China at UCB

Nov 27th 2020 11:00 to 12:00
AB 2103 / Online
Thursday, November 26, 2020 - 17:30

兴泉全球健康讲坛系列第126场

No.126 Aegon-Industrial Global Health Symposium Series

How is Real World Evidence Driving Impact in The Drug Life Cycle?

 

SPEAKER’S BIO:

Dr. Jiachen Zhou  is the RWE Lead China at UCB, a multinational biopharmaceutical company headquartered in Brussels, Belgium, where he leads the development and execution of all regional RWE related activities of the company. Previously Jiachen worked as a clinical epidemiologist at the telemedicine program of Philips Electronics North America.

Jiachen holds a Ph.D. in epidemiology from Brown University, specializing in chronic disease epidemiology, pharmacoepidemiology, and advanced research methodology. He is currently based in Shanghai.